tiprankstipranks
IRLAB Therapeutics AB Class A (SE:IRLAB.A)
:IRLAB.A
Sweden Market
IRLAB.A
IRLAB Therapeutics AB Class A
RESEARCH TOOLSreports
Want to see SE:IRLAB.A full AI Analyst Report?

IRLAB Therapeutics AB Class A (IRLAB.A) Ratios

1 Followers

IRLAB Therapeutics AB Class A Ratios

SE:IRLAB.A's free cash flow for Q1 2026 was kr0.24. For the 2026 fiscal year, SE:IRLAB.A's free cash flow was decreased by kr and operating cash flow was kr0.24. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.88 0.80 0.80 3.36 8.31
Quick Ratio
 0.88 0.80 0.80 3.36 8.19
Cash Ratio
 0.53 0.76 0.67 3.03 7.82
Solvency Ratio
 -0.66 -0.98 -0.76 -2.83 -3.37
Operating Cash Flow Ratio
 -0.95 -0.51 -0.66 -4.49 -4.41
Short-Term Operating Cash Flow Coverage
 -3.33 -2.09 -1.23 0.00 0.00
Net Current Asset Value
kr -11.45Mkr -21.62Mkr -24.02Mkr 62.23Mkr 235.96M
Leverage Ratios
Debt-to-Assets Ratio
 0.20 0.22 0.44 0.16 0.01
Debt-to-Equity Ratio
 0.68 0.98 1.85 0.24 0.01
Debt-to-Capital Ratio
 0.40 0.49 0.65 0.19 0.01
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.17 0.00
Financial Leverage Ratio
 3.39 4.50 4.17 1.53 1.11
Debt Service Coverage Ratio
 -1.18 -1.98 -1.06 -870.97 -370.11
Interest Coverage Ratio
 -3.83 -5.13 -7.17 -908.37 -380.84
Debt to Market Cap
 0.25 0.20 0.10 0.05 0.00
Interest Debt Per Share
 0.51 0.72 1.37 0.54 0.08
Net Debt to EBITDA
 0.49 0.59 0.10 0.48 2.28
Profitability Margins
Gross Profit Margin
-42.97%-160.71%-97.67%-2161.57%-181.94%
EBIT Margin
-57.35%-160.71%-76.78%-3128.58%-185.01%
EBITDA Margin
-52.77%-153.20%-71.93%-3052.55%-178.50%
Operating Profit Margin
-59.52%-160.71%-79.38%-3183.60%-185.01%
Pretax Profit Margin
-72.37%-191.45%-87.85%-3132.07%-185.50%
Net Profit Margin
-72.37%-191.45%-87.85%-3132.07%-186.80%
Continuous Operations Profit Margin
-72.37%-191.45%-87.85%-3132.07%-185.50%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.70%
EBT Per EBIT
121.59%119.13%110.67%98.38%100.26%
Return on Assets (ROA)
-49.56%-79.60%-61.03%-100.41%-35.30%
Return on Equity (ROE)
-275.71%-358.13%-254.73%-153.62%-39.27%
Return on Capital Employed (ROCE)
-138.13%-300.63%-207.66%-128.76%-38.84%
Return on Invested Capital (ROIC)
-82.23%-152.21%-80.72%-126.12%-38.37%
Return on Tangible Assets
-75.90%-120.43%-93.04%-136.53%-41.27%
Earnings Yield
-64.96%-83.35%-14.91%-38.96%-5.75%
Efficiency Ratios
Receivables Turnover
 2.81 14.31 4.59 0.63 5.00
Payables Turnover
 2.14 1.93 18.82 12.20 17.18
Inventory Turnover
 0.00 0.00 0.00 0.00 46.69
Fixed Asset Turnover
 20.86 10.50 9.66 0.85 7.63
Asset Turnover
 0.68 0.42 0.69 0.03 0.19
Working Capital Turnover Ratio
 -5.59 -2.73 2.85 0.04 0.21
Cash Conversion Cycle
 -40.66 -163.41 60.16 546.26 59.52
Days of Sales Outstanding
 130.07 25.50 79.56 576.17 72.94
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 7.82
Days of Payables Outstanding
 170.73 188.92 19.40 29.91 21.24
Operating Cycle
 130.07 25.50 79.56 576.17 80.76
Cash Flow Ratios
Operating Cash Flow Per Share
 -1.10 -0.82 -1.26 -3.18 -2.75
Free Cash Flow Per Share
 -1.10 -0.82 -1.27 -3.18 -2.82
CapEx Per Share
 0.00 0.00 <0.01 <0.01 0.07
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.02
Dividend Paid and CapEx Coverage Ratio
 0.00 0.00 -329.60 -562.63 -42.24
Capital Expenditure Coverage Ratio
 0.00 0.00 -329.60 -562.63 -42.24
Operating Cash Flow Coverage Ratio
 -3.33 -1.84 -1.09 -5.98 -35.87
Operating Cash Flow to Sales Ratio
 -0.98 -0.96 -0.69 -29.03 -2.33
Free Cash Flow Yield
-84.53%-41.84%-11.80%-36.18%-7.35%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -1.54 -1.20 -6.71 -2.57 -17.38
Price-to-Sales (P/S) Ratio
 1.15 2.30 5.89 80.39 32.47
Price-to-Book (P/B) Ratio
 2.59 4.30 17.09 3.94 6.83
Price-to-Free Cash Flow (P/FCF) Ratio
 -1.18 -2.39 -8.48 -2.76 -13.60
Price-to-Operating Cash Flow Ratio
 -1.14 -2.39 -8.50 -2.77 -13.92
Price-to-Earnings Growth (PEG) Ratio
 -1.24 -0.48 0.13 -0.05 0.05
Price-to-Fair Value
 2.59 4.30 17.09 3.94 6.83
Enterprise Value Multiple
 -1.70 -0.91 -8.10 -2.15 -15.91
Enterprise Value
 83.05M 80.08M 551.09M 372.70M 1.74B
EV to EBITDA
 -1.70 -0.91 -8.10 -2.15 -15.91
EV to Sales
 0.90 1.39 5.82 65.64 28.40
EV to Free Cash Flow
 -0.92 -1.45 -8.38 -2.26 -11.89
EV to Operating Cash Flow
 -0.92 -1.45 -8.40 -2.26 -12.18
Tangible Book Value Per Share
 -0.09 -0.24 -0.27 1.33 4.71
Shareholders’ Equity Per Share
 0.49 0.46 0.63 2.23 5.61
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 >-0.01
Revenue Per Share
 1.13 0.86 1.82 0.11 1.18
Net Income Per Share
 -0.82 -1.64 -1.60 -3.43 -2.20
Tax Burden
 1.00 1.00 1.00 1.00 1.01
Interest Burden
 1.26 1.19 1.14 1.00 1.00
Research & Development to Revenue
 1.04 2.28 1.73 26.65 2.39
SG&A to Revenue
 -0.50 -2.28 -1.73 0.00 2.06
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 1.50 0.50 0.79 0.93 1.26
Currency in SEK